4//SEC Filing
Kalkofen Donald A. 4
Accession 0001209191-20-014090
CIK 0001377121other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:45 PM ET
Size
5.5 KB
Accession
0001209191-20-014090
Insider Transaction Report
Form 4
Kalkofen Donald A.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-28+55,000→ 55,000 totalExercise: $7.80Exp: 2030-02-27→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 48 equal monthly installments following the date of grant.
Documents
Issuer
Protagonist Therapeutics, Inc
CIK 0001377121
Entity typeother
Related Parties
1- filerCIK 0001771066
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:45 PM ET
- Size
- 5.5 KB